Retatrutide + Cagrilintide Blend 10mg | 10-Vial Kit | Triple/Dual Agonist Stack

Description

What is Retatrutide + Cagrilintide Blend 10mg?

QSC Retatrutide + Cagrilintide Blend combines the triple GLP-1R/GIPR/GCGR agonist retatrutide with the amylin analog cagrilintide in a single pre-formulated vial. This creates a four-mechanism research stack: GLP-1R (appetite suppression + insulin), GIPR (enhanced adipocyte and insulin effects), GCGR (hepatic fat mobilisation + thermogenesis), and amylin receptor (meal size/frequency reduction via area postrema). This represents the most mechanistically comprehensive weight loss peptide combination currently available for research — exceeding the three-pathway retatrutide monotherapy and the two-pathway CagriSema combination.